abstract |
The present invention relates to an RNAi construct that reduces the expression of the ASGR1 gene. Methods of using such RNAi constructs to treat or prevent cardiovascular diseases such as coronary artery disease and myocardial infarction and to reduce the amount of serum non-HDL cholesterol are also described. |